0001628280-23-031149 Sample Contracts

MOONLAKE IMMUNOTHERAPEUTICS Class A Ordinary Shares (par value $0.0001 per share) SALES AGREEMENT
Sales Agreement • August 31st, 2023 • MoonLake Immunotherapeutics • Pharmaceutical preparations • New York

MoonLake Immunotherapeutics, a Cayman Islands exempted company (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC (the “Agent”), as follows:

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.